Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4860026
Max Phase: Preclinical
Molecular Formula: C50H56N6O6
Molecular Weight: 837.03
Molecule Type: Unknown
Associated Items:
ID: ALA4860026
Max Phase: Preclinical
Molecular Formula: C50H56N6O6
Molecular Weight: 837.03
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(CCCCCCC(=O)Nc1ccc2c(c1)[C@@]13CCN4CC5=CCO[C@H]6CC(=O)N2[C@H]1[C@H]6[C@H]5C[C@H]43)Nc1ccc2c(c1)[C@@]13CCN4CC5=CCO[C@H]6CC(=O)N2[C@H]1[C@H]6[C@H]5C[C@H]43
Standard InChI: InChI=1S/C50H56N6O6/c57-41(51-29-7-9-35-33(19-29)49-13-15-53-25-27-11-17-61-37-23-43(59)55(35)47(49)45(37)31(27)21-39(49)53)5-3-1-2-4-6-42(58)52-30-8-10-36-34(20-30)50-14-16-54-26-28-12-18-62-38-24-44(60)56(36)48(50)46(38)32(28)22-40(50)54/h7-12,19-20,31-32,37-40,45-48H,1-6,13-18,21-26H2,(H,51,57)(H,52,58)/t31-,32-,37-,38-,39-,40-,45-,46-,47-,48-,49+,50+/m0/s1
Standard InChI Key: FIDNROXWZXYOPU-LRMVCSOMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 837.03 | Molecular Weight (Monoisotopic): 836.4261 | AlogP: 5.42 | #Rotatable Bonds: 9 |
Polar Surface Area: 123.76 | Molecular Species: BASE | HBA: 8 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 12 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 13.92 | CX Basic pKa: 9.37 | CX LogP: 2.15 | CX LogD: -1.19 |
Aromatic Rings: 2 | Heavy Atoms: 62 | QED Weighted: 0.25 | Np Likeness Score: 1.00 |
1. Zlotos DP, Abdelmalek CM, Botros LS, Banoub MM, Mandour YM, Breitinger U, El Nady A, Breitinger HG, Sotriffer C, Villmann C, Jensen AA, Holzgrabe U.. (2021) C-2-Linked Dimeric Strychnine Analogues as Bivalent Ligands Targeting Glycine Receptors., 84 (2.0): [PMID:33596384] [10.1021/acs.jnatprod.0c01030] |
Source(1):